Federal Register: FDA Issues Notice of Draft Guidance on Container Closures and Device Constituent Parts for Biosimilars
August 01, 2026
August 01, 2026
WASHINGTON, Aug. 1 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts." This draft guidance is intended to help applicants devel . . .
* * *
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts." This draft guidance is intended to help applicants devel . . .